This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Renowned Los Angeles Bariatric Surgeon Dr. Michael Feiz Named A Fellow Of The American College Of Surgeons

LOS ANGELES, Feb. 28, 2013 /PRNewswire/ -- As an acknowledged master of weight loss surgery and a pioneer of such less invasive procedures as the gastric sleeve, respected bariatric surgeon Dr. Michael Feiz has helped innumerable Southern Californians and people from all over the world to reclaim the health and happiness they deserve. Now, Dr. Feiz has been accepted as a fellow of the highly prestigious American College of Surgeons. His entry into the organization's ranks allows the doctor to add the designation "F.A.C.S." after his name, alongside "M.D." Receiving this designation indicates that the physician has attained an extremely high level of documented skill and has maintained a high level of ethical practice.

Dr. Feiz's acceptance into the organization is recognition of his demonstrated level of achievement on an enormous range of weight-loss related procedures. He has performed innumerable sleeve gastrectomy, lap band and other innovative procedures. The surgeon has been praised not only for his high level of success, but for his sensitive approach in discussing the often touchy issues that accompany obesity and weight loss surgery. He has also been on the leading edge of approaches to weight loss, and he has been advocating further study of the ghrelin hormone, which is believed to be responsible for the nearly irresistible urges that cause overeating.

An applicant for Fellowship in the American College of Surgeons must be a graduate of an approved medical school; must have completed advanced training in one of the 14 surgical specialties recognized by the College; must possess certification by an American surgical specialty board; and must have been in practice in the same geographic location for at least one year at the time of his or her application.  Before admission into Fellowship, the surgeon must further demonstrate ethical fitness and professional proficiency, and his or her acceptance as a Fellow of the College must be approved by three-fourths of its Board of Regents.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs